Skip to content

Public FDA record

Z-1105-2021: Bemer-Set/ Pro-Set for the following models: REF. 410201 (BEMER Pro-Set), REF. 420201 (B.BOX Profession

Recall record Z-1105-2021 for BEMER INT. AG. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1105-2021
Company in FDA record
BEMER INT. AG
FDA record creation date
Feb 10, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There potential that electromagnetic fields generated in the therapy system may cause technical defects in a patient using an insulin pumps or a malfunction of a pacemaker.

Source facts

Action
On January 13, 2021, Bemer USA sent a "Urgent Safety Information" letter to affected consignees via E-Mail. In addition to informing consignees about the recall the firm asked consignees to take the following actions: 1. Patients who wear an active medical implant that leads to stimulation (e.g., pacemakers, defibrillators, brain stimulators, muscle stimulators) should not use the BEMER therapy system unless a specialist physician carries out a personal risk assessment and subsequently expressly tells the patient that he/she can continue the treatment. If you are an affected patient, please stop using the BEMER therapy system immediately and consult your specialist physician. The specialist physician will then decide whether or not you can continue using the BEMER therapy system. 2. In the risk assessment, your specialist physician must estimate whether or not the BEMER therapy can cause possible interference at a maximum flow density of 150 T (average flow density for total body treatment 21 T), based on the individually set threshold values of the implant and under consideration of the distance between the applicator (coil) and the pacemaker with its electrodes. If the specialist physician estimates that interference and therefore, operating safety, cannot be excluded, do not continue the BEMER therapy system treatment. 3. Patients wearing active medical implants designed to deliver medication (e.g., medication pumps) have an absolute contraindication. In other words, they may no longer use the BEMER therapy system. These contraindications must be observed by the user for future use. 4. If you have re-sold the aforementioned products in new condition to a third party, you are required to forward a copy of this notice to all your customers, including all professional users (doctors, therapists, hospitals, etc.). Alternatively, please inform the contact person listed below so we can ensure the compliance with this notice requirement. Your applicabl
Initiated
2021-01-13
Root cause
Labeling Change Control
Terminated
2023-07-12
Distribution
US
Recall number
Z-1105-2021
Recall status
Terminated
CDRH record ID
185325
FDA record created
2021-02-10
Recall event number
87094

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗